IRIS
SERTOLI, MARIO ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.696
AS - Asia 35
SA - Sud America 17
NA - Nord America 1
Totale 6.749
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.696
CN - Cina 20
BR - Brasile 14
VN - Vietnam 12
SG - Singapore 3
AR - Argentina 1
PE - Perù 1
PY - Paraguay 1
US - Stati Uniti d'America 1
Totale 6.749
Salva come PNG Salva come JPEG
Città #
Genova 4.229
Genoa 1.514
Rapallo 556
Vado Ligure 392
Beijing 8
Bordighera 5
Ho Chi Minh City 5
Hanoi 3
Aparecida de Goiânia 1
Ashburn 1
Caaporã 1
Can Tho 1
Canoas 1
Cedral 1
Chorrillos 1
Ciudad del Este 1
Curitiba 1
Duque de Caxias 1
Haiphong 1
Iporã 1
João Monlevade 1
Macaé 1
Nova Friburgo 1
Quilmes 1
Recife 1
Rio de Janeiro 1
Santa Vitória do Palmar 1
Torres 1
Totale 6.732
Salva come PNG Salva come JPEG
Nome #
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 204
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 187
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. 185
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. 168
"Autologous Bone Marrow Transplantation for Adult Advanced Stage Lymphoblastic Lymphoma in First CR. A Study of the NHLCSG". 162
Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review. 159
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 158
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. 157
Gene-expression profiling in vaccine therapy and immunotherapy for cancer. 152
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 147
Phase II study with high-dose N5-10-methyltetrahydrofolate and 5-fluorouracil in advanced colorectal cancer. 142
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 142
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 142
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 141
84: [Antibiotic preparation in operations on the large intestine. Experimental study] GF, Rollandi GA. 138
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial 138
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 136
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 133
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 133
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials 133
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis 131
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. 131
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials 130
VACOP-B Versus VACOP-B Plus Autologous Bone Marrow Transplantation for Advanced Diffuse Non-Hodgkin's Lymphoma: Results of a Prospective Randomized Trial by the Non-Hodgkin's Lymphoma Cooperative Study Group 128
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 127
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. 125
Improved chopping of a lithium beam for plasma edge diagnostic at ASDEX Upgrade. 125
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 124
[Antibiotic preparation in operations on the large intestine. Experimental study]. 121
Fattibilità della Terapia Adiuvante Intraperitoneale e Sistemica in Pazienti Operati Radicalmente per Carcinoma del Colon. 120
Randomized cooperative study of perioperative chemotherapy in breast cancer. 119
Heat shock proteins and their use as anticancer vaccines. 115
INK4/ARF germline alterations in pancreatic cancer patients 111
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 111
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2 108
Radiation-associated angiosarcoma: diagnostic and therapeutic implications--two case reports and a review of the literature. 108
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. 108
Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study. 107
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 106
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 100
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. 97
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. 94
Intraperitoneal infusion of recombinant interleukin-2 in malignant ascites in patients with gastrointestinal and ovarian cancer. 94
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascitis receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2) 88
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG 87
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. 87
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. 86
INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families 85
Sentinel lymph node biopsy in melanoma patients: the medical oncologist's perspective. 82
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma 78
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group. 72
Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation. 72
Merkel cell carcinoma of the skin. Treatment of primary, recurrent and metastatic disease: review of clinical cases. 67
La preparazione antibiotica negli interventi sul grosso intestino 66
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer 65
Mutazioni germinali al locus INK4/ARF in pazienti affetti da adenocarcinoma pancreatico in relazione alla storia oncologica familiare 58
La preparazione antibiotica negli interventi sul grosso intestino. Studio sperimentale 54
Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer 38
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 29
Totale 6.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.236
article - articoli 21.970
book - libri 0
conference - conferenze 266
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 33 41 28 33 33 44 22 24
2021/2022659 14 43 43 99 23 53 32 166 25 66 14 81
2022/2023655 63 56 5 79 113 114 6 41 112 1 57 8
2023/2024322 15 48 10 45 24 37 14 25 18 11 35 40
2024/20251.046 26 77 22 55 132 122 72 209 36 40 117 138
2025/2026500 194 45 113 148 0 0 0 0 0 0 0 0
Totale 6.811